Biotech

All Articles

Lilly blog posts a lot more positive records on its own weekly insulin possibility

.On the heels of an FDA turndown for its own primary rivalrous Novo Nordisk, Eli Lilly is picking up...

IN 8bio standstills phase 2 trial, lays off one-half of labor force

.Just a couple of months after dosing the first client in a period 2 test for newly diagnosed gliobl...

Lilly, Haya ink $1B biobuck being overweight treaty to search darker genome

.Eli Lilly's search for excessive weight intendeds has led it to the dark genome. The Big Pharma has...

ArsenalBio increases $325M, turns away from previous lead asset

.Toolbox Biosciences is going on up. The tissue treatment firm has added $325 million in ammo along ...

Lilly- backed weight-loss biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' marijuana usage medication fails phase 2b, steering Indivior to rethink $100M option

.Aelis Farma's chances of getting a fast, good selection on a $one hundred million possibility remit...

ProKidney standstills stage 3 trial not required for tissue therapy approval

.ProKidney has actually ceased one of a set of period 3 tests for its tissue therapy for kidney illn...

Vaxcyte climbs on 'sensational' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what professionals called "stunning" period 1/2 information for its 31-valent pneu...

Recursion's brain health condition test reveals insufficient documentation of efficacy

.Recursion has discovered by means of an early test of its own tech-enabled approach to medication r...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Call it a case of excellent chemistry: Acepodia, a biotech based upon Nobel Champion science, is ac...